CHRW's consistent efforts to reward its shareholders through dividend payments and share repurchases highlight its financial ...
Kopin Corporation ("Kopin" or "the Company") (Nasdaq: KOPN), a leading developer and provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays, ...
Q2 2026 Earnings Call November 12, 2025 4:00 AM ESTCompany ParticipantsSam GhezelbashSimon Michel - CEO & Member of ...
ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, ...